University of Brescia, NeMO Clinical Center for Neuromuscular Diseases Trials

University of Brescia, NeMO Clinical Center for Neuromuscular Diseases	Welcome, Profile Billing Logout

University of Brescia, NeMO Clinical Center for Neuromuscular Diseases

Welcome, Profile Billing Logout

0 Trials

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

COLOMBI, CHIARA

NuPower, NCT05162768 / 2021-003907-16: Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)

Active, not recruiting

102

Europe, US, RoW

Elamipretide, MTP-131, Placebo

Stealth BioTherapeutics Inc.

Mitochondrial Myopathies, Mitochondrial Pathology, Mitochondrial DNA Mutation, Mitochondrial Diseases, Mitochondrial DNA Deletion, Mitochondrial DNA Depletion, Mitochondrial Metabolism Defect, Mitochondrial Complex I Deficiency

09/24

10/24

RESILIENT, NCT05337553 / 2022-000193-25: A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy

Active, not recruiting

269

Europe, US, RoW

taldefgrobep alfa, BHV-2000, BMS-986089, Placebo

Biohaven Pharmaceuticals, Inc., Biohaven Pharmaceuticals, Inc, Biohaven Pharmaceuticals, Inc.

Spinal Muscular Atrophy, Neuromuscular Diseases, SMA

01/25

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites